Synopsis
PeerView is an independent, professional medical publishing company focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerView Publications, PeerView is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
Episodes
-
![Roy H. Decker, MD, PhD - The Era of Immunotherapy in Stage III NSCLC: Exploring the Evidence and Practicalities of Integrating Checkpoint Inhibition Into the Multimodal Treatment Arsenal]()
Roy H. Decker, MD, PhD - The Era of Immunotherapy in Stage III NSCLC: Exploring the Evidence and Practicalities of Integrating Checkpoint Inhibition Into the Multimodal Treatment Arsenal
11/03/2019 Duration: 58minThe Era of Immunotherapy in Stage III NSCLC: Exploring the Evidence and Practicalities of Integrating Checkpoint Inhibition Into the Multimodal Treatment Arsenal
-
![Anna F. Farago, MD, PhD - The TRK to Tumor-Agnostic Care in Solid Tumors: A Pathology-Focused Guide to the Clinical Role of TRK Fusions in Personalizing Cancer Therapy]()
Anna F. Farago, MD, PhD - The TRK to Tumor-Agnostic Care in Solid Tumors: A Pathology-Focused Guide to the Clinical Role of TRK Fusions in Personalizing Cancer Therapy
06/03/2019 Duration: 38minThe TRK to Tumor-Agnostic Care in Solid Tumors: A Pathology-Focused Guide to the Clinical Role of TRK Fusions in Personalizing Cancer Therapy
-
![Guy Young, MD - Defining the Role of Extended Half-Life Replacement Clotting Factors in the Modern Management of Hemophilia A]()
Guy Young, MD - Defining the Role of Extended Half-Life Replacement Clotting Factors in the Modern Management of Hemophilia A
01/03/2019 Duration: 38minDefining the Role of Extended Half-Life Replacement Clotting Factors in the Modern Management of Hemophilia A
-
![Edward S. Kim, MD, FACP - Beyond Clinical Trials: Can Real-World Evidence Provide a Roadmap for Long-Term Treatment Planning in EGFRMutation-Positive NSCLC?]()
Edward S. Kim, MD, FACP - Beyond Clinical Trials: Can Real-World Evidence Provide a Roadmap for Long-Term Treatment Planning in EGFRMutation-Positive NSCLC?
27/02/2019 Duration: 28minBeyond Clinical Trials: Can Real-World Evidence Provide a Roadmap for Long-Term Treatment Planning in EGFRMutation-Positive NSCLC?
-
![Lynette M. Sholl, MD - Molecular Testing for EGFR Mutations in the Context of a Changing Treatment Landscape, Evolving Testing Options, and Updated Guidelines: What Pathologists Need to Know and Do]()
Lynette M. Sholl, MD - Molecular Testing for EGFR Mutations in the Context of a Changing Treatment Landscape, Evolving Testing Options, and Updated Guidelines: What Pathologists Need to Know and Do
25/02/2019 Duration: 01h01minMolecular Testing for EGFR Mutations in the Context of a Changing Treatment Landscape, Evolving Testing Options, and Updated Guidelines: What Pathologists Need to Know and Do
-
![Gregory Piazza, MD, MS - Turning the Tide on Venous Thromboembolism: Applying Anticoagulation Best Practices to Reduce the Disease Burden]()
Gregory Piazza, MD, MS - Turning the Tide on Venous Thromboembolism: Applying Anticoagulation Best Practices to Reduce the Disease Burden
22/02/2019 Duration: 33minTurning the Tide on Venous Thromboembolism: Applying Anticoagulation Best Practices to Reduce the Disease Burden
-
![Naiyer Rizvi, MD - The Evolving Role of Immunotherapy as a Component of Multimodal Therapy in Earlier Stages of Lung Cancer: Rationale, Current Evidence, Key Trials, and Implications for Multidisciplinary Care]()
Naiyer Rizvi, MD - The Evolving Role of Immunotherapy as a Component of Multimodal Therapy in Earlier Stages of Lung Cancer: Rationale, Current Evidence, Key Trials, and Implications for Multidisciplinary Care
07/02/2019 Duration: 41minThe Evolving Role of Immunotherapy as a Component of Multimodal Therapy in Earlier Stages of Lung Cancer: Rationale, Current Evidence, Key Trials, and Implications for Multidisciplinary Care
-
![Paul M. Ridker, MD, MPH, FACC, FAHA - Looking Beyond Lipids: A Visual Guide to Targeting Vascular Inflammation in Atherosclerosis]()
Paul M. Ridker, MD, MPH, FACC, FAHA - Looking Beyond Lipids: A Visual Guide to Targeting Vascular Inflammation in Atherosclerosis
14/01/2019 Duration: 01h08minLooking Beyond Lipids: A Visual Guide to Targeting Vascular Inflammation in Atherosclerosis
-
![Marc S. Sabatine, MD, MPH - Following the Evidence: LDL-C as a Path to Reducing Cardiovascular Events—How Low Do We Go?]()
Marc S. Sabatine, MD, MPH - Following the Evidence: LDL-C as a Path to Reducing Cardiovascular Events—How Low Do We Go?
02/01/2019 Duration: 01h17minFollowing the Evidence: LDL-C as a Path to Reducing Cardiovascular Events—How Low Do We Go?
-
![Marilyn K. Glassberg, MD - Examining the IPF Patient’s Journey to Diagnosis, Appropriate Therapy, and Overall Individualized Care]()
Marilyn K. Glassberg, MD - Examining the IPF Patient’s Journey to Diagnosis, Appropriate Therapy, and Overall Individualized Care
26/11/2018 Duration: 41minExamining the IPF Patient’s Journey to Diagnosis, Appropriate Therapy, and Overall Individualized Care
-
![Jonathan Corren, MD - A MasterClass on New Avenues in Asthma Management: Finding the Right Patients for Targeted Therapies]()
Jonathan Corren, MD - A MasterClass on New Avenues in Asthma Management: Finding the Right Patients for Targeted Therapies
21/11/2018 Duration: 55minA MasterClass on New Avenues in Asthma Management: Finding the Right Patients for Targeted Therapies
-
![Loren del Mar Pena, MD, PhD - Expert Insights on Available and Emerging Therapies for the Management of Pompe Disease]()
Loren del Mar Pena, MD, PhD - Expert Insights on Available and Emerging Therapies for the Management of Pompe Disease
19/11/2018 Duration: 24minExpert Insights on Available and Emerging Therapies for the Management of Pompe Disease
-
![Mark T. Reding, MD - Treatment Innovation in hemophilia A: Integrating Extended Half-Life Replacement Clotting Factors Into Clinical Practice]()
Mark T. Reding, MD - Treatment Innovation in hemophilia A: Integrating Extended Half-Life Replacement Clotting Factors Into Clinical Practice
12/11/2018 Duration: 38minTreatment Innovation in hemophilia A: Integrating Extended Half-Life Replacement Clotting Factors Into Clinical Practice
-
![Mario Castro, MD - An Expert Analysis of New Data for Uncontrolled Persistent Asthma Treatments: Clinical Updates From Paris]()
Mario Castro, MD - An Expert Analysis of New Data for Uncontrolled Persistent Asthma Treatments: Clinical Updates From Paris
31/10/2018 Duration: 40minAn Expert Analysis of New Data for Uncontrolled Persistent Asthma Treatments: Clinical Updates From Paris
-
![Nathan H. Fowler, MD - Innovative Therapy in B-Cell Malignancies: An Expert Tumor Board on Novel Agent Classes in CLL, FL, and MCL]()
Nathan H. Fowler, MD - Innovative Therapy in B-Cell Malignancies: An Expert Tumor Board on Novel Agent Classes in CLL, FL, and MCL
17/10/2018 Duration: 01h16minInnovative Therapy in B-Cell Malignancies: An Expert Tumor Board on Novel Agent Classes in CLL, FL, and MCL
-
![Kevin R. Flaherty, MD, MS - Progressive Fibrosing Interstitial Lung Disease: Shining a Light on the Latest Clinical Advances]()
Kevin R. Flaherty, MD, MS - Progressive Fibrosing Interstitial Lung Disease: Shining a Light on the Latest Clinical Advances
08/10/2018 Duration: 19minProgressive Fibrosing Interstitial Lung Disease: Shining a Light on the Latest Clinical Advances
-
![Javed Butler, MD, MPH - Examining the Role of Family Physicians in the Early Recognition and Management of Chronic Heart Failure]()
Javed Butler, MD, MPH - Examining the Role of Family Physicians in the Early Recognition and Management of Chronic Heart Failure
28/09/2018 Duration: 44minExamining the Role of Family Physicians in the Early Recognition and Management of Chronic Heart Failure
-
![Luca Richeldi, MD, PhD - Improving Care in ILD: Accurate Interpretation of HRCT and Advancing Therapies for Treatment]()
Luca Richeldi, MD, PhD - Improving Care in ILD: Accurate Interpretation of HRCT and Advancing Therapies for Treatment
29/08/2018 Duration: 18minImproving Care in ILD: Accurate Interpretation of HRCT and Advancing Therapies for Treatment
-
![Kristin B. Highland, MD, MSCR - Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD): Expert Insights on Current Management and Emerging Therapy]()
Kristin B. Highland, MD, MSCR - Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD): Expert Insights on Current Management and Emerging Therapy
10/08/2018 Duration: 01h01minSystemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD): Expert Insights on Current Management and Emerging Therapy
-
![Nick H. Kim, MD - Pulmonary Hypertension at the Crossroads of Current Clinical Challenges and Novel Therapeutic Strategies]()
Nick H. Kim, MD - Pulmonary Hypertension at the Crossroads of Current Clinical Challenges and Novel Therapeutic Strategies
08/08/2018 Duration: 51minPulmonary Hypertension at the Crossroads of Current Clinical Challenges and Novel Therapeutic Strategies
